|PROSIGNA PACKAGE INSERT|
|Prosigna Product Data Sheet|
|nCounter® Dx Analysis System User Manual (MAN-C0034)|
|Roche FFPET Kit
|1. Go to https://dialog1.roche.com/PI/us/eLabDoc
2. Enter REF number printed on the outside of the Roche kit box
3. Choose the newest version of Method Sheet and download
*Veracyte has acquired the Prosigna test. Materials are in transition.
Prosigna is indicated for in vitro diagnostic use in postmenopausal women with hormone receptor-positive, node-negative (Stage I or II), or node-positive (Stage II) breast cancer to be treated with adjuvant endocrine therapy for assessment of risk of distant recurrence of disease.